Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has announcements × Leukemia, Myelogenous, Chronic, BCR-ABL Positive × ALT-803 × Clear all

Sponsor

Conditions

Urinary Bladder Neoplasms 1 Non-Muscle Invasive Bladder Neoplasms 1

Interventions

nilotinib 6 bosutinib 4 asciminib 3 Imatinib Mesylate 3 Dasatinib 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡